249 related articles for article (PubMed ID: 30286855)
21. Efficacy and safety of a biodegradable polymer Cobalt-Chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: A pooled analysis of the CREDIT II and CREDIT III trials.
Wang G; Wang H; Xu B; Yang Y; Yang Z; Li H; Zhang Z; Wang H; Yang L; Han Y
Catheter Cardiovasc Interv; 2017 Mar; 89(S1):512-519. PubMed ID: 28112473
[TBL] [Abstract][Full Text] [Related]
22. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry.
Moscarella E; Ielasi A; Beneduce A; Ferrante G; Pivato CA; Chiarito M; Cappelletti A; Perfetti G; Magni V; Prati E; Falcone S; Pierri A; De Martini S; Montorfano M; Parisi R; Rutigliano D; Locuratolo N; Anzuini A; Calabrò P; Tespili M; Margonato A; Benassi A; Briguori C; Fabbiocchi F; Reimers B; Bartorelli A; Colombo A; Godino C
Catheter Cardiovasc Interv; 2019 Dec; 94(7):972-979. PubMed ID: 31037840
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.
Raungaard B; Christiansen EH; Bøtker HE; Hansen HS; Ravkilde J; Thuesen L; Aarøe J; Villadsen AB; Terkelsen CJ; Krusell LR; Maeng M; Kristensen SD; Veien KT; Hansen KN; Junker A; Madsen M; Andersen SL; Jensen SE; Jensen LO;
JACC Cardiovasc Interv; 2017 Feb; 10(3):255-264. PubMed ID: 28109874
[TBL] [Abstract][Full Text] [Related]
24. Mid-term outcome of biolimus-eluting stents with biodegradable polymer: results from a multinational prospective 'all-comers' registry.
Kretov EI; Baystrukov VI; Boukhris M; Prokhorikhin AA; Grazhdankin IO; Abcha F; Biryukov AV; Verin VV; Zubarev DD; Naydenov RA; Naryshkin IA; Ponomarev DN; Mahmoud SE; Galassi AR; Obedinskiy AA
Coron Artery Dis; 2017 Sep; 28(6):457-464. PubMed ID: 28379855
[TBL] [Abstract][Full Text] [Related]
25. Three-year follow up of biodegradable polymer cobalt-chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: Pooled analysis of CREDIT II and CREDIT III trials.
Wang G; Ma G; Tao L; Yuan Z; Liu H; Hu X; Tong Q; Yu Z; Zhou X; Han Y
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():565-571. PubMed ID: 31944543
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One-year results from a prospective patient-level pooled analysis of NeoVas trials.
Xu K; Fu G; Xu B; Zhou Y; Su X; Liu H; Zhang Z; Yu B; Wang X; Han Y;
Catheter Cardiovasc Interv; 2019 Feb; 93(S1):832-838. PubMed ID: 30888736
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of an ultrathin-strut sirolimus-eluting stent in all-comers population: Thailand Orsiro registry.
Suwannasom P; Athiksakul S; Thonghong T; Lertsuwunseri V; Chaipromprasit J; Srimahachota S; Udayachalerm W; Kuanprasert S; Buddhari W
BMC Cardiovasc Disord; 2021 Oct; 21(1):501. PubMed ID: 34656088
[TBL] [Abstract][Full Text] [Related]
28. One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.
Chandrasekhar J; de Winter VC; Kalkman DN; Sartori S; Chandiramani R; Aquino MB; de Wilde P; Zeebregts D; Woudstra P; Beijk MA; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Coufal Z; Lee M; Tijssen JG; Koch KT; Baber U; Dangas GD; Colombo A; de Winter RJ; Mehran R;
Cardiovasc Drugs Ther; 2021 Apr; 35(2):309-320. PubMed ID: 33515411
[TBL] [Abstract][Full Text] [Related]
29. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
30. 1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration.
Chandrasekhar J; Zeebregts D; Kalkman DN; Sartori S; Roumeliotis A; Aquino MB; de Wilde P; de Winter VC; Baber U; Woudstra P; Beijk MA; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Lee M; Tijssen JG; Koch KT; Dangas GD; Colombo A; Mehran R; de Winter RJ;
Cardiovasc Revasc Med; 2020 Dec; 21(12):1542-1547. PubMed ID: 32507695
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry.
Kerkmeijer LS; Kalkman DN; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; Van't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Cardiovasc Revasc Med; 2020 May; 21(5):567-570. PubMed ID: 31662276
[TBL] [Abstract][Full Text] [Related]
32. Impact of diabetes on clinical outcomes after revascularization with sirolimus-eluting and biolimus-eluting stents with biodegradable polymer from the SORT OUT VII trial.
Ellert J; Christiansen EH; Maeng M; Raungaard B; Jensen SE; Kristensen SD; Veien KT; Junker AB; Jakobsen L; Aarøe J; Terkelsen CJ; Kahlert J; Villadsen AB; Bøtker HE; Jensen LO
Catheter Cardiovasc Interv; 2019 Mar; 93(4):567-573. PubMed ID: 30244533
[TBL] [Abstract][Full Text] [Related]
33. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.
Nardin M; Pivato CA; Cao D; Sartori S; Zhang Z; Vogel B; Nicolas J; Chiarito M; Qiu H; Chandrasekhar J; Spirito A; Abizaid A; Christiansen EH; Colombo A; de Winter RJ; Haude M; Jakobsen L; Jensen LO; Krucoff MW; Landmesser U; Saito S; Suryapranata H; De Luca G; Dangas G; Mehran R
Int J Cardiol; 2023 Jan; 370():149-155. PubMed ID: 36270496
[TBL] [Abstract][Full Text] [Related]
34. Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization.
Yamaji K; Zanchin T; Zanchin C; Stortecky S; Koskinas KC; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Valgimigli M; Billinger M; Pilgrim T; Heg D; Windecker S; Räber L
Circ Cardiovasc Interv; 2018 Sep; 11(9):e006741. PubMed ID: 30354590
[TBL] [Abstract][Full Text] [Related]
35. The BIOFLOW-III Italian Satellite Registry: 18-month results of the Orsiro stent in an all-comer high-risk population.
Bartorelli AL; Versaci F; Briguori C; Tomai F; Aprigliano G; Poli A; Vigna C; Marinucci L; My L; Masi F; Turturo M
J Cardiovasc Med (Hagerstown); 2019 Jul; 20(7):464-470. PubMed ID: 30994511
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
Lee SW; Lam SC; Tam FC; Chan KK; Shea CP; Kong SL; Wong AY; Yung A; Zhang LW; Tse HF; Wu KK; Chan R; Haude M; Mehran R; Mintz GS; Maehara A
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418609
[TBL] [Abstract][Full Text] [Related]
37. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
[TBL] [Abstract][Full Text] [Related]
38. Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents.
Jakobsen L; Christiansen EH; Maeng M; Hansen KN; Kristensen SD; Bøtker HE; Terkelsen CJ; Jensen SE; Raungaard B; Madsen M; Lassen JF; Jensen LO
EuroIntervention; 2017 Dec; 13(11):1336-1344. PubMed ID: 28846543
[TBL] [Abstract][Full Text] [Related]
39. Randomized comparison of novel biodegradable polymer and durable polymer-coated cobalt-chromium sirolimus-eluting stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial.
Song L; Li J; Guan C; Jing Q; Lu S; Yang L; Xu K; Yang Y; Xu B; Han Y;
Catheter Cardiovasc Interv; 2018 Feb; 91(S1):608-616. PubMed ID: 29322619
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome.
Kalkman DN; Woudstra P; Lu H; Menown IBA; den Heijer P; Suryapranata H; Iñiguez A; Arkenbout KE; Van't Hof AWJ; Muller P; Erglis A; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2017 Aug; 90(2):E31-E37. PubMed ID: 28145609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]